Agentix Corp. (AGTX) stock
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 0/30
$0.02+0.00 (0.00%)
Close on Oct 16, 2026Market cap $801.34KP/E –Yield –
Agentix r&d expenses
Research and development expenses are spending on new products and technology.
Agentix's R&D Expenses for the twelve months ending Jun 30, 2026 was $41.71K, down 81.5% year over year. For fiscal 2026 it was $125.08K, down 30.9% from the year before. The highest annual figure on record is $365.13K in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $125.08K | -30.9% |
| FY2025 | Mar 31, 2025 | $180.99K | +3.3% |
| FY2024 | Mar 31, 2024 | $175.27K | -52.0% |
| FY2021 | Aug 31, 2021 | $365.13K | +9789.8% |
| FY2016 | Aug 31, 2016 | $3.69K | -87.0% |
| FY2015 | Aug 31, 2015 | $28.33K | -54.1% |
| FY2014 | Aug 31, 2014 | $61.75K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $16.64K | -83.4% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $0 | -100.0% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $0 | -100.0% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $25.08K | +111.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $100.00K | +80.2% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $90.35K | +96.3% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $23.29K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $11.85K | -79.7% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $55.50K | -64.9% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $46.02K | -59.6% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$87.30K | -251.8% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $58.37K | -67.3% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $158.18K | +921.3% |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | $113.91K | +8294.4% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | $57.50K | – |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | $178.33K | +10427.3% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | $15.49K | +1139.0% |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | $1.36K | +81.4% |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | $0 | -100.0% |
| Q3 FY2016CQ2 2016 | May 31, 2016 | $1.69K | +1594.0% |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | $1.25K | -93.5% |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | $748 | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | $5.51K | – |
| Q3 FY2015CQ2 2015 | May 31, 2015 | $100 | – |
| Q2 FY2015CQ1 2015 | Feb 28, 2015 | $19.30K | – |
See a number that looks wrong?